Search alternatives:
"point decrease" » "point increase" (Expand Search)
"rate increased" » "cases increased" (Expand Search)
"unit decrease" » "unit increase" (Expand Search)
"point decrease" » "point increase" (Expand Search)
"rate increased" » "cases increased" (Expand Search)
"unit decrease" » "unit increase" (Expand Search)
-
41
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
42
-
43
-
44
-
45
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
46
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
47
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
48
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
49
-
50
-
51
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
52
Heteropolyacid Ligands in Two-Dimensional Channels Enable Lithium Separation from Monovalent Cations
Published 2025Subjects: -
53
Heteropolyacid Ligands in Two-Dimensional Channels Enable Lithium Separation from Monovalent Cations
Published 2025Subjects: -
54
Heteropolyacid Ligands in Two-Dimensional Channels Enable Lithium Separation from Monovalent Cations
Published 2025Subjects: -
55
Heteropolyacid Ligands in Two-Dimensional Channels Enable Lithium Separation from Monovalent Cations
Published 2025Subjects: -
56
-
57
-
58
-
59
-
60